Cipla lost 4.9% at Rs 470.65 at 9:19 IST on BSE after consolidated net profit fell 68.9% to Rs 81 crore on 5.6% growth in income from operations to Rs 3267 crore in Q4 March 2016 over Q4 March 2015.
The result was announced after market hours yesterday, 24 May 2016.Meanwhile, the S&P BSE Sensex was up 302.97 points or 1.2% at 25,608.44.
On BSE, so far 1.13 lakh shares were traded in the counter as against average daily volume of 1.28 lakh shares in the past two weeks. The stock hit a low of Rs 467.30 so far during the day, which is a 52-week low for the counter. The stock hit a high of Rs 480.10 so far during the day. The stock had hit a 52-week high of Rs 748 on 17 August 2015.
The large-cap company has equity capital of Rs 160.69 crore. Face value per share is Rs 2.
The company's earnings before interest, taxation, depreciation and amortization (EBITDA) declined 56.9% to Rs 219 crore in Q4 March 2016 over Q4 March 2015.
Cipla is a global pharmaceutical company. The company's portfolio includes over 1,500 products across wide range of therapeutic categories with one quality standard globally.
Powered by Capital Market - Live News
